• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期心力衰竭的 INTERMACS 分型:现状

INTERMACS profiles of advanced heart failure: the current picture.

作者信息

Stevenson Lynne Warner, Pagani Francis D, Young James B, Jessup Mariell, Miller Leslie, Kormos Robert L, Naftel David C, Ulisney Karen, Desvigne-Nickens Patrice, Kirklin James K

机构信息

Brigham & Women's Hospital, Boston, Massachusetts, USA.

出版信息

J Heart Lung Transplant. 2009 Jun;28(6):535-41. doi: 10.1016/j.healun.2009.02.015.

DOI:10.1016/j.healun.2009.02.015
PMID:19481012
Abstract

BACKGROUND

The current classification of patients with New York Heart Association Class IV symptoms does not offer adequate description to allow optimal selection of patients for the current options of medical and pacing therapies, cardiac transplantation and mechanical circulatory support.

METHODS

Seven clinical profiles and an arrhythmia modifier were developed and implemented into the first year of data collection for the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). The INTERMACS Coordinators' Council provided ongoing feedback regarding the characterization of patients receiving implantable devices.

RESULTS

The definition of 7 clinical profiles revealed that 80% of current devices are being used in the 2 profiles with the highest levels of clinical compromise. The INTERMACS Coordinators' Council helped to identify gaps in the characterization of hospitalized patients on temporary assist devices and of homebound patients with resting symptoms, which has led to revised definitions of Profile 3 and 4 and the addition of 2 new modifiers, for temporary circulatory support devices in the hospital, and for frequent rehospitalization of patients at home.

CONCLUSIONS

Patients considered for mechanical circulatory support can now be classified using the 7 profiles plus 3 modifiers developed through INTERMACS. Further understanding these profiles and their impact on outcome should help to better select patients and therapies in the advanced stages of disease.

摘要

背景

纽约心脏协会IV级症状患者的当前分类无法提供充分描述,以允许为当前的药物和起搏治疗、心脏移植及机械循环支持选择最佳患者。

方法

制定了七种临床特征及一种心律失常修正因素,并在机构间机械辅助循环支持注册中心(INTERMACS)数据收集的第一年实施。INTERMACS协调员委员会就接受植入设备患者的特征描述提供持续反馈。

结果

七种临床特征的定义显示,当前80%的设备用于临床损害程度最高的两种特征患者。INTERMACS协调员委员会帮助确定了临时辅助设备住院患者及有静息症状居家患者特征描述方面的差距,这导致对特征3和4的定义进行了修订,并增加了2个新的修正因素,分别针对医院中的临时循环支持设备以及居家患者的频繁再次住院情况。

结论

现在可使用通过INTERMACS制定的7种特征加3个修正因素对考虑接受机械循环支持的患者进行分类。进一步了解这些特征及其对结局的影响应有助于在疾病晚期更好地选择患者和治疗方法。

相似文献

1
INTERMACS profiles of advanced heart failure: the current picture.晚期心力衰竭的 INTERMACS 分型:现状
J Heart Lung Transplant. 2009 Jun;28(6):535-41. doi: 10.1016/j.healun.2009.02.015.
2
INTERMACS: interval analysis of registry data.INTERMACS:登记数据的区间分析
J Am Coll Surg. 2009 May;208(5):755-61; discussion 761-2. doi: 10.1016/j.jamcollsurg.2008.11.016. Epub 2009 Feb 1.
3
Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry.术前 INTERMACS 评分可预测行急诊心脏移植的危重症患者的术后结局:西班牙国家心脏移植登记研究分析。
Circ Heart Fail. 2013 Jul;6(4):763-72. doi: 10.1161/CIRCHEARTFAILURE.112.000237. Epub 2013 May 14.
4
Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.INTERMACS量表对预测机械辅助装置植入术后结局的有效性。
J Heart Lung Transplant. 2009 Aug;28(8):827-33. doi: 10.1016/j.healun.2009.04.033.
5
The Fourth INTERMACS Annual Report: 4,000 implants and counting.《第四份 INTERMACS 年度报告:4000 例植入,且仍在增加》。
J Heart Lung Transplant. 2012 Feb;31(2):117-26. doi: 10.1016/j.healun.2011.12.001.
6
INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.INTERMACS(机械辅助循环支持跨机构注册中心)分析可识别因心力衰竭住院后接受药物治疗的高危门诊患者。
Circ Heart Fail. 2016 Nov;9(11). doi: 10.1161/CIRCHEARTFAILURE.116.003032.
7
Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification.根据术前 INTERMACS 分类对连续血流左心室辅助装置患者的临床结局进行分层。
J Heart Lung Transplant. 2011 Apr;30(4):402-7. doi: 10.1016/j.healun.2010.10.016. Epub 2010 Dec 18.
8
Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances).作为移植或康复桥梁的机械循环支持疗法(新进展)
Curr Opin Cardiol. 2006 Mar;21(2):120-6. doi: 10.1097/01.hco.0000210308.64360.8d.
9
INTERMACS database for durable devices for circulatory support: first annual report.用于循环支持的耐用设备的INTERMACS数据库:第一份年度报告。
J Heart Lung Transplant. 2008 Oct;27(10):1065-72. doi: 10.1016/j.healun.2008.07.021.
10
Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients.术前白细胞介素-6 水平与机械循环辅助支持患者 Interagency Registry for Mechanically Assisted Circulatory Support 特征和重症监护病房停留的相关性。
J Heart Lung Transplant. 2012 Jun;31(6):625-33. doi: 10.1016/j.healun.2012.02.006. Epub 2012 Mar 3.

引用本文的文献

1
History and Application of Mechanical Assist Devices as a Bridge to Heart Transplant: A Review and Perspectives in Brazil.作为心脏移植桥梁的机械辅助装置的历史与应用:巴西的综述与展望
Braz J Cardiovasc Surg. 2025 Aug 14;40(6). doi: 10.21470/1678-9741-2025-0906.
2
Prognostic value of the vasoactive-inotropic score in predicting outcomes following LVAD implantation.血管活性-正性肌力评分对左心室辅助装置植入术后预后的预测价值。
JHLT Open. 2025 Apr 24;9:100272. doi: 10.1016/j.jhlto.2025.100272. eCollection 2025 Aug.
3
The role of temporary mechanical circulatory support in heart failure.
临时机械循环支持在心力衰竭中的作用。
Eur Heart J Suppl. 2025 Feb 4;27(Suppl 4):iv39-iv46. doi: 10.1093/eurheartjsupp/suaf002. eCollection 2025 Apr.
4
Profiling of Cardiogenic Shock: Incorporating Machine Learning Into Bedside Management.心源性休克的剖析:将机器学习纳入床边管理
J Soc Cardiovasc Angiogr Interv. 2024 May 28;4(3Part B):102047. doi: 10.1016/j.jscai.2024.102047. eCollection 2025 Mar.
5
Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Preliminary Cost-Effectiveness Analysis in the Italian Context.意大利背景下因心源性休克患者使用Impella与VA-ECMO的初步成本效益分析
Cardiol Ther. 2025 Jun;14(2):183-198. doi: 10.1007/s40119-025-00404-w. Epub 2025 Mar 28.
6
The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure.钠-葡萄糖协同转运蛋白2抑制剂在心力衰竭各阶段的作用及早期临床获益机制:从预防到晚期心力衰竭
Biomedicines. 2025 Mar 3;13(3):608. doi: 10.3390/biomedicines13030608.
7
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort.预测重度心力衰竭患者的生存率:HELP-HF队列中的风险评分验证
Eur J Heart Fail. 2025 Apr;27(4):726-736. doi: 10.1002/ejhf.3585. Epub 2025 Jan 20.
8
Heart failure outpatient clinics resources in Italy: a viewpoint of Italian Society of Cardiology organization.意大利心力衰竭门诊资源:意大利心脏病学会组织的观点
Heart Fail Rev. 2025 May;30(3):505-513. doi: 10.1007/s10741-024-10480-0. Epub 2025 Jan 8.
9
Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support?接受Impella 5.5支持的患者出现不良结局是否存在特定病因的风险因素?
JTCVS Open. 2024 Apr 23;21:123-137. doi: 10.1016/j.xjon.2024.04.014. eCollection 2024 Oct.
10
Trajectories following Impella 5.5 support are associated with initial presentation acuity.使用Impella 5.5支持装置后的轨迹与初始表现的敏锐度相关。
Artif Organs. 2025 Jan;49(1):137-145. doi: 10.1111/aor.14867. Epub 2024 Oct 18.